nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Nilutamide—prostate cancer	0.189	0.294	CbGbCtD
Ximelagatran—CYP2C9—Bicalutamide—prostate cancer	0.189	0.294	CbGbCtD
Ximelagatran—CYP2C9—Estrone—prostate cancer	0.113	0.176	CbGbCtD
Ximelagatran—CYP2C9—Capecitabine—prostate cancer	0.0857	0.134	CbGbCtD
Ximelagatran—CYP2C9—Estradiol—prostate cancer	0.065	0.101	CbGbCtD
Ximelagatran—F2—urine—prostate cancer	0.0267	0.408	CbGeAlD
Ximelagatran—CYP2C9—urine—prostate cancer	0.0106	0.163	CbGeAlD
Ximelagatran—F2—prostate gland—prostate cancer	0.00959	0.146	CbGeAlD
Ximelagatran—F2—epithelium—prostate cancer	0.00705	0.108	CbGeAlD
Ximelagatran—F2—renal system—prostate cancer	0.00654	0.0998	CbGeAlD
Ximelagatran—F2—bone marrow—prostate cancer	0.00494	0.0755	CbGeAlD
Ximelagatran—F2—Signaling Pathways—GRB7—prostate cancer	7.14e-05	0.000244	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDE4D—prostate cancer	7.14e-05	0.000244	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	7.05e-05	0.00024	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—prostate cancer	7.01e-05	0.000239	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ITPR1—prostate cancer	6.99e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIST1H4H—prostate cancer	6.96e-05	0.000237	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—prostate cancer	6.95e-05	0.000237	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	6.92e-05	0.000236	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—JAK2—prostate cancer	6.81e-05	0.000232	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	6.81e-05	0.000232	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GNG5—prostate cancer	6.79e-05	0.000232	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CBR1—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CSAD—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GRHL1—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSAT1—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TST—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADI1—prostate cancer	6.68e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	6.53e-05	0.000223	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—prostate cancer	6.47e-05	0.000221	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	6.4e-05	0.000218	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INS—prostate cancer	6.29e-05	0.000214	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.25e-05	0.000213	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GRHPR—prostate cancer	6.21e-05	0.000212	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UGT2B17—prostate cancer	6.21e-05	0.000212	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CKMT2—prostate cancer	6.21e-05	0.000212	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UGT2B15—prostate cancer	6.21e-05	0.000212	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—prostate cancer	6.08e-05	0.000207	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	6.07e-05	0.000207	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	5.97e-05	0.000204	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—prostate cancer	5.94e-05	0.000203	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTHLH—prostate cancer	5.91e-05	0.000202	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFBR1—prostate cancer	5.91e-05	0.000202	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—prostate cancer	5.88e-05	0.000201	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MBTPS1—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PGAM2—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RFK—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SULT2B1—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM3—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAGLU—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AOX1—prostate cancer	5.84e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKR1C3—prostate cancer	5.82e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKACB—prostate cancer	5.79e-05	0.000197	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	5.7e-05	0.000195	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP3CA—prostate cancer	5.64e-05	0.000193	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—THBS1—prostate cancer	5.64e-05	0.000193	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ANXA1—prostate cancer	5.56e-05	0.00019	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A43—prostate cancer	5.53e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AMACR—prostate cancer	5.53e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT1—prostate cancer	5.53e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SRD5A2—prostate cancer	5.53e-05	0.000189	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DEGS1—prostate cancer	5.53e-05	0.000189	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCZ—prostate cancer	5.46e-05	0.000186	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	5.44e-05	0.000186	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	5.41e-05	0.000184	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—prostate cancer	5.34e-05	0.000182	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EP300—prostate cancer	5.33e-05	0.000182	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B1—prostate cancer	5.28e-05	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	5.28e-05	0.00018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PARP1—prostate cancer	5.27e-05	0.00018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR4—prostate cancer	5.27e-05	0.00018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALCA—prostate cancer	5.21e-05	0.000178	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—prostate cancer	5.18e-05	0.000177	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL12—prostate cancer	5.09e-05	0.000174	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	5.07e-05	0.000173	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—prostate cancer	5.05e-05	0.000172	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	5.05e-05	0.000172	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	5e-05	0.00017	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—prostate cancer	4.89e-05	0.000167	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—prostate cancer	4.84e-05	0.000165	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP9—prostate cancer	4.79e-05	0.000163	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	4.76e-05	0.000162	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGD—prostate cancer	4.7e-05	0.00016	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—B4GALT4—prostate cancer	4.7e-05	0.00016	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—prostate cancer	4.69e-05	0.00016	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGFR—prostate cancer	4.64e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCQ—prostate cancer	4.64e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—prostate cancer	4.63e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAP3K7—prostate cancer	4.59e-05	0.000156	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—prostate cancer	4.51e-05	0.000154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TNFRSF21—prostate cancer	4.42e-05	0.000151	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF10—prostate cancer	4.41e-05	0.00015	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADRB2—prostate cancer	4.36e-05	0.000149	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—JAK2—prostate cancer	4.3e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP7B1—prostate cancer	4.3e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTAP—prostate cancer	4.3e-05	0.000147	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—prostate cancer	4.29e-05	0.000146	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAP2K1—prostate cancer	4.29e-05	0.000146	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—prostate cancer	4.26e-05	0.000145	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VAV3—prostate cancer	4.25e-05	0.000145	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.2e-05	0.000143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFBR2—prostate cancer	4.19e-05	0.000143	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SULT1E1—prostate cancer	4.19e-05	0.000143	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SRD5A1—prostate cancer	4.19e-05	0.000143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ITPR1—prostate cancer	4.13e-05	0.000141	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—prostate cancer	4.09e-05	0.000139	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.07e-05	0.000139	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.01e-05	0.000137	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B3—prostate cancer	4e-05	0.000136	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACSL4—prostate cancer	4e-05	0.000136	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	3.95e-05	0.000135	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—prostate cancer	3.95e-05	0.000135	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—prostate cancer	3.94e-05	0.000135	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—prostate cancer	3.93e-05	0.000134	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—JAK2—prostate cancer	3.91e-05	0.000133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PHGDH—prostate cancer	3.83e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UMPS—prostate cancer	3.83e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ARG2—prostate cancer	3.83e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	3.82e-05	0.00013	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—prostate cancer	3.81e-05	0.00013	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LPL—prostate cancer	3.78e-05	0.000129	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LDHB—prostate cancer	3.76e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—prostate cancer	3.75e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDGFRB—prostate cancer	3.75e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—prostate cancer	3.71e-05	0.000127	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A5—prostate cancer	3.69e-05	0.000126	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ITGB3—prostate cancer	3.65e-05	0.000125	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—prostate cancer	3.57e-05	0.000122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TCN2—prostate cancer	3.56e-05	0.000122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA3—prostate cancer	3.56e-05	0.000122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PDHA1—prostate cancer	3.56e-05	0.000122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UCP3—prostate cancer	3.56e-05	0.000122	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB3—prostate cancer	3.54e-05	0.000121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR2—prostate cancer	3.54e-05	0.000121	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—prostate cancer	3.41e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC22A3—prostate cancer	3.4e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD3B1—prostate cancer	3.4e-05	0.000116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—prostate cancer	3.4e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.3e-05	0.000113	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TBXAS1—prostate cancer	3.26e-05	0.000111	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA4—prostate cancer	3.26e-05	0.000111	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—prostate cancer	3.25e-05	0.000111	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—prostate cancer	3.22e-05	0.00011	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.19e-05	0.000109	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA2—prostate cancer	3.18e-05	0.000108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—prostate cancer	3.17e-05	0.000108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—prostate cancer	3.14e-05	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG5—prostate cancer	3.14e-05	0.000107	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SULT1A1—prostate cancer	3.14e-05	0.000107	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—prostate cancer	3.11e-05	0.000106	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA1—prostate cancer	3.07e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAT2—prostate cancer	3.03e-05	0.000103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD3B2—prostate cancer	3.03e-05	0.000103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTO1—prostate cancer	3.03e-05	0.000103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—prostate cancer	3.03e-05	0.000103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BAD—prostate cancer	2.96e-05	0.000101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.91e-05	9.94e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLCB2—prostate cancer	2.91e-05	9.92e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C18—prostate cancer	2.91e-05	9.92e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LRP2—prostate cancer	2.91e-05	9.92e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—prostate cancer	2.86e-05	9.77e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—prostate cancer	2.86e-05	9.77e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—P4HB—prostate cancer	2.85e-05	9.72e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGF—prostate cancer	2.83e-05	9.65e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS1—prostate cancer	2.83e-05	9.65e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC22A1—prostate cancer	2.77e-05	9.46e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3B—prostate cancer	2.75e-05	9.37e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.74e-05	9.35e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INS—prostate cancer	2.71e-05	9.24e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SULT2A1—prostate cancer	2.7e-05	9.22e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MED12—prostate cancer	2.66e-05	9.07e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CREBBP—prostate cancer	2.65e-05	9.05e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GNG5—prostate cancer	2.64e-05	9e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—prostate cancer	2.62e-05	8.94e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—prostate cancer	2.61e-05	8.9e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA3—prostate cancer	2.54e-05	8.67e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAP2K1—prostate cancer	2.53e-05	8.64e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—prostate cancer	2.52e-05	8.58e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.5e-05	8.52e-05	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—prostate cancer	2.49e-05	8.5e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—prostate cancer	2.49e-05	8.49e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—prostate cancer	2.46e-05	8.4e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGDS—prostate cancer	2.42e-05	8.27e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF2—prostate cancer	2.41e-05	8.22e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C19—prostate cancer	2.41e-05	8.22e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—prostate cancer	2.38e-05	8.11e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—prostate cancer	2.35e-05	8.02e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACHE—prostate cancer	2.35e-05	8.02e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2A6—prostate cancer	2.32e-05	7.93e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.31e-05	7.9e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAK2—prostate cancer	2.31e-05	7.88e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—prostate cancer	2.26e-05	7.72e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKR1C3—prostate cancer	2.26e-05	7.71e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MDM2—prostate cancer	2.25e-05	7.69e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRKACB—prostate cancer	2.25e-05	7.67e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.22e-05	7.59e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—prostate cancer	2.22e-05	7.58e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.19e-05	7.49e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—prostate cancer	2.19e-05	7.48e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA2—prostate cancer	2.12e-05	7.23e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—prostate cancer	2.11e-05	7.19e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—prostate cancer	2.06e-05	7.02e-05	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—prostate cancer	2.04e-05	6.95e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.02e-05	6.9e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—prostate cancer	2.02e-05	6.88e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—prostate cancer	2.01e-05	6.87e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—prostate cancer	2e-05	6.84e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.98e-05	6.74e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—prostate cancer	1.96e-05	6.7e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NQO1—prostate cancer	1.95e-05	6.66e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—prostate cancer	1.94e-05	6.63e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TH—prostate cancer	1.93e-05	6.57e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.91e-05	6.53e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—prostate cancer	1.91e-05	6.5e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.9e-05	6.5e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1A—prostate cancer	1.9e-05	6.48e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.9e-05	6.47e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—prostate cancer	1.89e-05	6.47e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.87e-05	6.39e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—prostate cancer	1.85e-05	6.31e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GGT1—prostate cancer	1.81e-05	6.19e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EP300—prostate cancer	1.81e-05	6.17e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA1—prostate cancer	1.79e-05	6.1e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.76e-05	6.01e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—prostate cancer	1.76e-05	6e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—prostate cancer	1.71e-05	5.84e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RXRA—prostate cancer	1.7e-05	5.8e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—prostate cancer	1.69e-05	5.78e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.65e-05	5.64e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COMT—prostate cancer	1.64e-05	5.58e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—prostate cancer	1.63e-05	5.56e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ITPR1—prostate cancer	1.6e-05	5.47e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.58e-05	5.38e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—prostate cancer	1.57e-05	5.37e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—prostate cancer	1.57e-05	5.36e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—prostate cancer	1.54e-05	5.26e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—prostate cancer	1.51e-05	5.17e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—prostate cancer	1.5e-05	5.11e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPL—prostate cancer	1.47e-05	5.01e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—prostate cancer	1.46e-05	4.96e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.42e-05	4.84e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ERCC2—prostate cancer	1.41e-05	4.8e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—prostate cancer	1.34e-05	4.56e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—prostate cancer	1.32e-05	4.51e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARA—prostate cancer	1.3e-05	4.43e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—prostate cancer	1.29e-05	4.41e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—prostate cancer	1.22e-05	4.16e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—prostate cancer	1.18e-05	4.04e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.17e-05	3.98e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.11e-05	3.79e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—prostate cancer	1.09e-05	3.73e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INS—prostate cancer	1.05e-05	3.59e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CREBBP—prostate cancer	1.03e-05	3.52e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—prostate cancer	9.77e-06	3.33e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—prostate cancer	9.23e-06	3.15e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.52e-06	2.91e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—prostate cancer	8.44e-06	2.88e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—prostate cancer	7.36e-06	2.51e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EP300—prostate cancer	7.02e-06	2.4e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.19e-06	1.77e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—prostate cancer	4.24e-06	1.45e-05	CbGpPWpGaD
